The sell-off in Humana is overdone after strong earnings. Jim Cramer says buy the stock

Health, Fitness & Food

In this photo illustration, Humana Inc. logo seen displayed on a tablet.
Getty Images

The post-earnings decline in Humana (HUM) shares Wednesday was overdone, providing investors an opportunity to add to their positions in the Medicare Advantage-focused health insurer.

The Club holding remains on solid ground after delivering a top- and bottom-line beat in the third quarter.

Products You May Like

Articles You May Like

Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
I Unlocked the Power of My Deepest Core Muscles, and I’ve Never Felt Stronger
Free 7 Day Healthy Meal Plan (March 3-9)
French Onion Chicken Soup
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

Leave a Reply

Your email address will not be published. Required fields are marked *